Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · see citing works

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660 · see citing works

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861 · see citing works

Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · see citing works

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556 · see citing works

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825 · see citing works

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

Vermes, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.171 · Cited by 803 · see citing works

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784 · see citing works

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · see citing works

Frequency and Evolution of Azole Resistance in <i>Aspergillus fumigatus</i> Associated with Treatment Failure1

Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750 · see citing works

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

Snelders, E., van der Lee, H. A. L., Kuijpers, J., Rijs, A. J. M. M., Varga, J., Samson, R. A., Mellado, E., Donders, A. R. T., Melchers, W. J. G., & Verweij, P. E. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050219 · Cited by 726 · see citing works

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707 · see citing works

Candida auris: a Review of the Literature

Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K. J., Johnson, E. M., Borman, A. M., Candida auris Incident Management Team, Manuel, R. J., & Brown, C. S. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-17 · Cited by 610 · see citing works

Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

Verweij, P. E., Snelders, E., Kema, G. H., Mellado, E., & Melchers, W. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70265-8 · Cited by 604 · see citing works

Amphotericin forms an extramembranous and fungicidal sterol sponge

Anderson, T. M., Clay, M. C., Cioffi, A. G., Diaz, K. A., Hisao, G. S., Tuttle, M. D., Nieuwkoop, A. J., Comellas, G., Maryum, N., Wang, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1496 · Cited by 528 · see citing works

Resistance to echinocandin-class antifungal drugs.

Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · see citing works

Itraconazole resistance in Aspergillus fumigatus

Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 507 · see citing works

Antimicrobial heteroresistance: An emerging field in need of clarity

El-Halfawy, O. M., & Valvano, M. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-14 · Cited by 489 · see citing works

Cryptococcus neoformans Overcomes Stress of Azole Drugs by Formation of Disomy in Specific Multiple Chromosomes

Sionov, E., Lee, H., Chang, Y. C., & Kwon-Chung, K. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000848 · Cited by 479 · see citing works

Resistance Mechanisms in Clinical Isolates of <i>Candida albicans</i>

White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1704-1713.2002 · Cited by 461 · see citing works

Clinical Implications of Azole Resistance inAspergillus fumigatus, the Netherlands, 2007–2009

van der Linden, J. W. M., Snelders, E., Kampinga, G. A., Rijnders, B. J. A., Mattsson, E., Debets-Ossenkopp, Y. J., Kuijper, E. J., van Tiel, F. H., Melchers, W. J. G., & Verweij, P. E. (2011) · Emerging infectious diseases · doi:10.3201/eid1710.110226 · Cited by 445 · see citing works

Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus

Snelders, E., Camps, S. M. T., Karawajczyk, A., Schaftenaar, G., Kema, G. H. J., van der Lee, H. A., Klaassen, C. H. W., Melchers, W. J. G., & Verweij, P. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031801 · Cited by 427 · see citing works

Multiple-Triazole–Resistant Aspergillosis

Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380 · see citing works

Echinocandin resistance in Candida.

Perlin, D. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ791 · Cited by 374 · see citing works

Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance

Carolus, H., Pierson, S., Lagrou, K., & Dijck, P. V. (2020) · Journal of Fungi · doi:10.3390/jof6040321 · Cited by 364 · see citing works

The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans

Morschhäuser, J., Barker, K. S., Liu, T. T., Blaß-Warmuth, J., Homayouni, R., & Rogers, P. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030164 · Cited by 355 · see citing works

High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene

Singh, A. K., Masih, A., Khurana, A., et al. (2018) · Mycoses · doi:10.1111/myc.12772 · Cited by 349 · see citing works

Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles

van der Linden, J. W. M., Camps, S. M. T., Kampinga, G. A., Arends, J. P. A., Debets-Ossenkopp, Y. J., Haas, P. J. A., Rijnders, B. J. A., Kuijper, E. J., van Tiel, F. H., Varga, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit320 · Cited by 342 · see citing works

Terbinafine Resistance of Trichophyton Clinical Isolates Caused by Specific Point Mutations in the Squalene Epoxidase Gene

Yamada, T., Maeda, M., Alshahni, M. M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00115-17 · Cited by 341 · see citing works

Mechanisms of echinocandin antifungal drug resistance

Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313 · see citing works

The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus

Fraczek, M. G., Bromley, M., Buied, A., Moore, C. B., Rajendran, R., Rautemaa‐Richardson, R., Ramage, G., Denning, D. W., & Bowyer, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt075 · Cited by 313 · see citing works

Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study

Lestrade, P. P. A., Bentvelsen, R. G., Schauwvlieghe, A. F. A. D., Schalekamp, S., van der Velden, W. J. F. M., Kuiper, E. J., van Paassen, J., van der Hoven, B., van der Lee, H. A., Melchers, W. J. G., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy859 · Cited by 310 · see citing works

Echinocandin resistance: an emerging clinical problem?

Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299 · see citing works

History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action

Shafiei, M., Peyton, L., Hashemzadeh, M., & Foroumadi, A. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104240 · Cited by 295 · see citing works

Contribution of Clinically Derived Mutations in <i>ERG11</i> to Azole Resistance in Candida albicans

Flowers, S. A., Colón, B., Whaley, S. G., Schuler, M. A., & Rogers, P. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03470-14 · Cited by 294 · see citing works

Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation

Sanglard, D., Coste, A., & Ferrari, S. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00578.x · Cited by 285 · see citing works

Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature

Morio, F., Loge, C., Besse, B., Hennequin, C., & Le Pape, P. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.11.006 · Cited by 279 · see citing works

Alarming India‐wide phenomenon of antifungal resistance in dermatophytes: A multicentre study

Ebert, A., Monod, M., Salamin, K., Burmester, A., Uhrlaß, S., Wiegand, C., Hipler, U., Krüger, C., Koch, D., Wittig, F., et al. (2020) · Mycoses · doi:10.1111/myc.13091 · Cited by 279 · see citing works

Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.

Helweg-Larsen, J., Benfield, T. L., Eugen-Olsen, J., Lundgren, J. D., & Lundgren, B. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03320-6 · Cited by 274 · see citing works

Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance

Rudramurthy, S. M., Shankarnarayan, S. A., Dogra, S., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02522-17 · Cited by 272 · see citing works

Trichophyton indotineae sp. nov.: A New Highly Terbinafine-Resistant Anthropophilic Dermatophyte Species

Kano, R., Kimura, U., Kakurai, M., et al. (2020) · Mycopathologia · doi:10.1007/s11046-020-00455-8 · Cited by 270 · see citing works

Fungal echinocandin resistance

Walker, L. A., Gow, N. A. R., & Munro, C. A. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.09.003 · Cited by 267 · see citing works

The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors

Zhang, J., Li, L., Lv, Q., Yan, L., Wang, Y., & Jiang, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00691 · Cited by 249 · see citing works

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)

Arendrup, M. C., Friberg, N., Ma, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Arendrup, M., Meletiadis, J., Guinea, J., Friberg, N., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.007 · Cited by 248 · see citing works

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

Kordalewska, M., Lee, A., Park, S., Berrio, I., Chowdhary, A., Zhao, Y., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-18 · Cited by 247 · see citing works

Symptomatic Relapse of HIV‐Associated Cryptococcal Meningitis after Initial Fluconazole Monotherapy: The Role of Fluconazole Resistance and Immune Reconstitution

Bicanic, T. A., Harrison, T. S., Niepieklo, A., Dyakopu, N., & Meintjes, G. (2006) · Clinical Infectious Diseases · doi:10.1086/507895 · Cited by 222 · see citing works

Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance

Carolus, H., Pierson, S., Muñoz, J. F., Subotić, A., Cruz, R. B., Cuomo, C. A., & Van Dijck, P. (2021) · mBio · doi:10.1128/mbio.03333-20 · Cited by 211 · see citing works

Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus

Rodrı́guez-Tudela, J. L., Alcázar‐Fuoli, L., Mellado, E., Alastruey‐Izquierdo, A., Monzón, A., & Cuenca‐Estrella, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00156-08 · Cited by 209 · see citing works

Discovery of a hapE Mutation That Causes Azole Resistance in Aspergillus fumigatus through Whole Genome Sequencing and Sexual Crossing

Camps, S. M. T., Dutilh, B. E., Arendrup, M. C., Rijs, A. J. M. M., Snelders, E., Huynen, M. A., Verweij, P. E., & Melchers, W. J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050034 · Cited by 208 · see citing works

Taxonomy of the Trichophyton mentagrophytes/T. interdigitale Species Complex Harboring the Highly Virulent, Multiresistant Genotype T. indotineae

Tang, C., Kong, X., Ahmed, S. A., Thakur, R., Chowdhary, A., Nenoff, P., Uhrlaß, S., Verma, S. B., Meis, J. F. G. M., Kandemir, H., et al. (2021) · Mycopathologia · doi:10.1007/s11046-021-00544-2 · Cited by 207 · see citing works

Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata

Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 204 · see citing works

Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate

Slaven, J. W., Anderson, M. J., Sanglard, D., Dixon, G. K., Bille, J., Roberts, I. S., & Denning, D. W. (2002) · Fungal Genetics and Biology · doi:10.1016/s1087-1845(02)00016-6 · Cited by 202 · see citing works

Multi-azole resistance in Aspergillus fumigatus

Howard, S. J., Webster, I., Moore, C. B., Gardiner, R. E., Park, S., Perlin, D. S., & Denning, D. W. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.017 · Cited by 202 · see citing works

Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance

Alcázar‐Fuoli, L., & Mellado, E. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00439 · Cited by 187 · see citing works

Heteroresistance to Fluconazole in <i>Cryptococcus neoformans</i> Is Intrinsic and Associated with Virulence

Sionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179 · see citing works

<i>Cryptococcus neoformans</i> Resistance to Echinocandins: (1,3)β-Glucan Synthase Activity Is Sensitive to Echinocandins

Maligie, M. A., & Selitrennikoff, C. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2851-2856.2005 · Cited by 178 · see citing works

FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia

Beyda, N. D., John, J., Kilic, A., Alam, M. J., Lasco, T. M., & Garey, K. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu407 · Cited by 174 · see citing works

Emerging Terbinafine Resistance in Trichophyton : Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection

Saunte, D. M. L., Hare, R. K., Jørgensen, K. M., Jørgensen, R., Deleuran, M. S., Zachariae, C. O. C., Thomsen, S. F., Bjørnskov-Halkier, L., Kofoed, K., & Arendrup, M. C. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01126-19 · Cited by 172 · see citing works

Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.

Kazanjian, P., Locke, A. B., Hossler, P. A., Lane, B. R., Bartlett, M. S., Smith, J. W., Cannon, M., & Meshnick, S. R. (1998) · AIDS · doi:10.1097/00002030-199808000-00009 · Cited by 171 · see citing works

Spread of Terbinafine-Resistant Trichophyton mentagrophytes Type VIII (India) in Germany–“The Tip of the Iceberg?”

Nenoff, P., Verma, S. B., Ebert, A., et al. (2020) · Journal of Fungi · doi:10.3390/jof6040207 · Cited by 170 · see citing works

Identification and Characterization of Four Azole-Resistant <i>erg3</i> Mutants of <i>Candida albicans</i>

Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Rolley, N., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00348-10 · Cited by 168 · see citing works

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis

Stone, N. R. H., Rhodes, J., Fisher, M. C., Mfinanga, S., Kivuyo, S., Rugemalila, J., Segal, E. S., Needleman, L., Molloy, S. F., Kwon-Chung, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124516 · Cited by 167 · see citing works

A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?

Kidd, S. E., Chen, S. C. ‐., Meyer, W., & Halliday, C. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02903 · Cited by 167 · see citing works

Validation of a New Aspergillus Real-Time PCR Assay for Direct Detection of Aspergillus and Azole Resistance of Aspergillus fumigatus on Bronchoalveolar Lavage Fluid

Chong, G. M., van de Sande, W. W. J., Dingemans, G., Gaajetaan, G. R., Vonk, A. G., Hayette, M., van Tegelen, D. W. E., Simons, G., & Rijnders, B. J. A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03216-14 · Cited by 153 · see citing works

Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China

Jiang, C., Dong, D., Yu, B., Cai, G., Wang, X., Ji, Y., & Peng, Y. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks481 · Cited by 153 · see citing works

A systematic review of fluconazole resistance in clinical isolates ofCryptococcusspecies

Bongomin, F., Oladele, R. O., Gago, S., Moore, C. B., & Richardson, M. D. (2018) · Mycoses · doi:10.1111/myc.12747 · Cited by 153 · see citing works

Sulfa or Sulfone Prophylaxis and Geographic Region Predict Mutations in the<i>Pneumocystis carinii</i>Dihydropteroate Synthase Gene

Huang, L., Beard, C. B., Creasman, J., Levy, D., Duchin, J. S., Lee, S., Pieniazek, N., Carter, J. L., del Rio, C., Rimland, D., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315824 · Cited by 149 · see citing works

Amino Acid Substitution inTrichophyton rubrumSqualene Epoxidase Associated with Resistance to Terbinafine

Osborne, C. S., Leitner, I., Favre, B., & Ryder, N. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2840-2844.2005 · Cited by 149 · see citing works

Acquired itraconazole resistance in Aspergillus fumigatus

Dannaoui, É. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.333 · Cited by 145 · see citing works

Identification and characterization of a <i>Cryptococcus neoformans</i> ATP binding cassette (ABC) transporter‐encoding gene, <i>CnAFR1</i>, involved in the resistance to fluconazole

Posteraro, B., Sanguinetti, M., Sanglard, D., La Sorda, M., Boccia, S., Romano, L., Morace, G., & Fadda, G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03281.x · Cited by 143 · see citing works

In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management

Verweij, P. E., Zhang, J., Debets, A. J. M., Meis, J. F., van de Veerdonk, F. L., Schoustra, S. E., Zwaan, B. J., & Melchers, W. J. G. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30138-4 · Cited by 140 · see citing works

Heteroresistance to Fluconazole and Voriconazole in <i>Cryptococcus neoformans</i>

Mondon, P., Petter, R., Amalfitano, G., Luzzati, R., Concia, E., Polacheck, I., & Kwon-Chung, K. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1856 · Cited by 139 · see citing works

High prevalence of antifungal resistance in Candida spp. from patients with AIDS

Law, D., Moore, C. B., Wardle, H. M., Ganguli, L. A., Keaney, M. G. L., & Denning, D. W. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.5.659 · Cited by 139 · see citing works

G484S Amino Acid Substitution in Lanosterol 14-α Demethylase ( <i>ERG11</i> ) Is Related to Fluconazole Resistance in a Recurrent <i>Cryptococcus neoformans</i> Clinical Isolate

Rodero, L., Mellado, E., Rodriguez, A. C., Salve, A., Guelfand, L., Cahn, P., Cuenca-Estrella, M., Davel, G., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3653-3656.2003 · Cited by 139 · see citing works

<i>FKS</i> Mutations and Elevated Echinocandin MIC Values among <i>Candida glabrata</i> Isolates from U.S. Population-Based Surveillance

Zimbeck, A. J., Iqbal, N., Ahlquist, A. M., Farley, M. M., Harrison, L. H., Chiller, T., & Lockhart, S. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00836-10 · Cited by 136 · see citing works

Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside

Aruanno, M., Glampedakis, E., & Lamoth, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00399-19 · Cited by 136 · see citing works

Recent trends in molecular diagnostics of yeast infections: from PCR to NGS

Arastehfar, A. A., Boekhout, T., Butler, G., Cesare, G. B. D., Dolk, E., Gabaldón, T., Hafez, A. I., Hube, B., Hagen, F., Hovhannisyan, H., et al. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz015 · Cited by 136 · see citing works

Sequence Polymorphisms in thePneumocystis cariniiCytochromebGene and Their Association with Atovaquone Prophylaxis Failure

Walker, D. J., Wakefield, A. E., Dohn, M. N., Miller, R. F., Baughman, R. P., Hossler, P. A., Bartlett, M. S., Smith, J. W., Kazanjian, P. H., & Meshnick, S. R. (1998) · The Journal of Infectious Diseases · doi:10.1086/314509 · Cited by 134 · see citing works

Correlation of In Vitro Susceptibility Based on MICs and Squalene Epoxidase Mutations with Clinical Response to Terbinafine in Patients with Tinea Corporis/Cruris

Khurana, A., Masih, A., Chowdhary, A., Sardana, K., Borker, S. A., Gupta, A., Gautam, R. K., Sharma, P. K., & Jain, D. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01038-18 · Cited by 134 · see citing works

Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans

Dodgson, A. R., Dodgson, K. J., Pujol, C., Pfaller, M. A., & Soll, D. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2223-2227.2004 · Cited by 133 · see citing works

Resistance to amphotericin B associated with defective sterol<i>Δ</i>^8→7isomerase in a<i>Cryptococcus neoformans</i>strain from an AIDS patient

Kelly, S. L., Lamb, D. C., Taylor, M., Corran, A. J., Baldwin, B. C., & Powderly, W. G. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07140.x · Cited by 133 · see citing works

The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus

Furukawa, T., van Rhijn, N., Fraczek, M. G., Gsaller, F., Davies, E. A., Carr, P. D., Gago, S., Fortune‐Grant, R., Rahman, S., Gilsenan, J. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14191-1 · Cited by 133 · see citing works

PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay ® in 201 patients with haematological disease suspected for invasive aspergillosis

Chong, G. M., van der Beek, M. T., Borne, P. A. V. D., Boelens, J., Steel, E., Kampinga, G. A., Span, L. F. R., Lagrou, K., Maertens, J. A., Dingemans, G., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw323 · Cited by 132 · see citing works

Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications

Forastiero, A., Mesa-Arango, A. C., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Pelaez, T., Lopez, J. F., Grimalt, J. O., Gomez-Lopez, A., Cuesta, I., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00477-13 · Cited by 131 · see citing works

Mutations in <i>hmg1</i> , Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus

Rybak, J. M., Ge, W., Wiederhold, N. P., Parker, J. E., Kelly, S. L., Rogers, P. D., & Fortwendel, J. R. (2019) · mBio · doi:10.1128/mbio.00437-19 · Cited by 130 · see citing works

A Novel Environmental Azole Resistance Mutation in <i>Aspergillus fumigatus</i> and a Possible Role of Sexual Reproduction in Its Emergence

Zhang, J., Snelders, E., Zwaan, B. J., Schoustra, S. E., Meis, J. F., van Dijk, K., Hagen, F., van der Beek, M. T., Kampinga, G. A., Zoll, J., et al. (2017) · mBio · doi:10.1128/mbio.00791-17 · Cited by 129 · see citing works

Multiple-azole-resistantAspergillus fumigatusosteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery

Hodiamont, C. J., Dolman, K. M., ten Berge, I. J. M., Melchers, W. J. G., Verweij, P. E., & Pajkrt, D. (2008) · Medical Mycology · doi:10.1080/13693780802545600 · Cited by 122 · see citing works

Identification of a Cryptococcus neoformans Cytochrome P450 Lanosterol 14α-Demethylase (Erg11) Residue Critical for Differential Susceptibility between Fluconazole/Voriconazole and Itraconazole/Posaconazole

Sionov, E., Chang, Y. C., Garraffo, H. M., Dolan, M. A., Ghannoum, M. A., & Kwon-Chung, K. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05502-11 · Cited by 120 · see citing works

Role of the ABC transporter TruMDR2 in terbinafine, 4-nitroquinoline N-oxide and ethidium bromide susceptibility in Trichophyton rubrum

Fachin, A. L., Ferreira-Nozawa, M. S., Maccheroni, W., et al. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46522-0 · Cited by 120 · see citing works

Meta-analysis of diagnostic procedures forPneumocystis cariniipneumonia in HIV-1-infected patients

Cruciani, M., Marcati, P., Malena, M., Bosco, O., Serpelloni, G., & Mengoli, C. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.01372002 · Cited by 119 · see citing works

Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria

Biagi, M. J., Wiederhold, N. P., Gibas, C. F. C., Wickes, B. L., Lozano, V., Bleasdale, S. C., & Danziger, L. H. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz262 · Cited by 118 · see citing works

Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study.

Navin, T. R., Beard, C. B., Huang, L., del Rio, C., Lee, S., Pieniazek, N. J., Carter, J. L., Le, T., Hightower, A., & Rimland, D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05705-1 · Cited by 117 · see citing works

Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic

Saunte, D. M. L., Pereiro, M., Rodríguez‐Cerdeira, C., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17241 · Cited by 116 · see citing works

Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus : the Challenge of Azoles versus Echinocandins

Arendrup, M. C., Perkhofer, S., Howard, S. J., García‐Effrón, G., Aimanianda, V., Perlin, D. S., & Lass‐Flörl, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00190-08 · Cited by 115 · see citing works

Role of AFR1 , an ABC Transporter-Encoding Gene, in the In Vivo Response to Fluconazole and Virulence of Cryptococcus neoformans

Sanguinetti, M., Posteraro, B., Sorda, M. L., Torelli, R., Fiori, B., Santangelo, R., Delogu, G., & Fadda, G. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1352-1359.2006 · Cited by 115 · see citing works

Trichophyton rubrum Azole Resistance Mediated by a New ABC Transporter, TruMDR3

Monod, M., Feuermann, M., Salamin, K., Fratti, M., Makino, M., Alshahni, M. M., Makimura, K., & Yamada, T. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00863-19 · Cited by 115 · see citing works

Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans

Castanheira, M., Deshpande, L. M., Davis, A. P., Rhomberg, P. R., & Pfaller, M. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-17 · Cited by 114 · see citing works

The structure–function relationship of the Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis: The mechanism of L98H azole resistance

Snelders, E., Karawajczyk, A., Verhoeven, R. J. A., Venselaar, H., Schaftenaar, G., Verweij, P. E., & Melchers, W. J. G. (2011) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2011.08.002 · Cited by 113 · see citing works

Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A)

Barros, M. E. D. S., Santos, D. A., & Hamdan, J. S. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46542-0 · Cited by 113 · see citing works

Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species

Dudakova, A., Spiess, B., Tangwattanachuleeporn, M., Sasse, C., Buchheidt, D., Weig, M., Groß, U., & Bader, O. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00095-16 · Cited by 113 · see citing works

Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance

Trotter, A. J., Aydin, A., Strinden, M. J., & O’Grady, J. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.03.001 · Cited by 113 · see citing works

Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs during Testing of Serum Samples

White, P. L., Posso, R. B., & Barnes, R. A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00667-15 · Cited by 112 · see citing works

Azole heteroresistance in Cryptococcus neoformans: Emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment

Sionov, E., Chang, Y. C., & Kwon-Chung, K. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00694-13 · Cited by 112 · see citing works

5-Fluorocytosine Resistance in Cryptococcus neoformans

Block, E. R., Jennings, A. E., & Bennett, J. E. (1973) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.3.6.649 · Cited by 112 · see citing works

Echinocandins: the expanding antifungal armamentarium

Aguilar-Zapata, D., Petraitiene, R., & Petraitis, V. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ814 · Cited by 112 · see citing works

Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata

Ferrari, S., Sanguinetti, M., Torelli, R., Posteraro, B., & Sanglard, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017589 · Cited by 110 · see citing works

Increasing Terbinafine Resistance in Danish Trichophyton Isolates 2019–2020

Astvad, K. M. T., Hare, R. K., Jørgensen, K. M., et al. (2022) · Journal of Fungi · doi:10.3390/jof8020150 · Cited by 107 · see citing works

Terbinafine

McClellan, K. J., Wiseman, L. R., & Markham, A. (1999) · Drugs · doi:10.2165/00003495-199958010-00018 · Cited by 106 · see citing works

Drug resistance in Cryptococcus neoformans

Perfect, J. R., & Cox, G. M. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0090 · Cited by 106 · see citing works

Non- cyp51A Azole-Resistant Aspergillus fumigatus Isolates with Mutation in HMG-CoA Reductase

Hagiwara, D., Arai, T., Takahashi, H., Kusuya, Y., Watanabe, A., & Kamei, K. (2018) · Emerging infectious diseases · doi:10.3201/eid2410.180730 · Cited by 105 · see citing works

Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination

Castanheira, M., Deshpande, L. M., Messer, S. A., Rhomberg, P. R., & Pfaller, M. A. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.09.003 · Cited by 105 · see citing works

Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophytonmentagrophytes Type VIII Locally and Globally

Siopi, M., Efstathiou, I., Theodoropoulos, K., Pournaras, S., & Meletiadis, J. (2021) · Journal of Fungi · doi:10.3390/jof7060419 · Cited by 104 · see citing works

Heteroresistance of <i>Cryptococcus gattii</i> to Fluconazole

Varma, A., & Kwon-Chung, K. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-10 · Cited by 103 · see citing works

5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus

Billmyre, R. B., Applen Clancey, S., Li, L. X., Doering, T. L., & Heitman, J. (2020) · Nature Communications · doi:10.1038/s41467-019-13890-z · Cited by 102 · see citing works

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

van Ingen, J., van der Lee, H. A., Rijs, T. A. J., Zoll, J., Leenstra, T., Melchers, W. J. G., & Verweij, P. E. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku364 · Cited by 101 · see citing works

In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates

Buil, J. B., Rijs, A. J. M. M., Meis, J. F. G. M., Birch, M., Law, D., Melchers, W. J. G., & Verweij, P. E. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx177 · Cited by 100 · see citing works

Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management

Perlin, D. S. (2014) · Drugs · doi:10.1007/s40265-014-0286-5 · Cited by 99 · see citing works

Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002

Sar, B. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh361 · Cited by 99 · see citing works

Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside

Cuenca‐Estrella, M. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12495 · Cited by 97 · see citing works

Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013

van Paassen, J., Russcher, A., Wingerden, A. W. M. I. V.-V., Verweij, P. E., & Kuijper, E. J. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.30.30300 · Cited by 96 · see citing works

Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance<i>in vivo</i>in<i>Candida albicans</i>orchestrated by multiple genetic alterations

Jensen, R. H., Astvad, K. M. T., Silva, L. V., Sanglard, D., Jørgensen, R., Nielsen, K. F., Mathiasen, E. G., Doroudian, G., Perlin, D. S., & Arendrup, M. C. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv140 · Cited by 95 · see citing works

First Detection of TR 46 /Y121F/T289A and TR 34 /L98H Alterations in Aspergillus fumigatus Isolates from Azole-Naive Patients in Denmark despite Negative Findings in the Environment

Astvad, K. M. T., Jensen, R. H., Hassan, T. M., Mathiasen, E. G., Thomsen, G. M., Pedersen, U. G., CHRISTENSEN, M. B., Hilberg, O., & Arendrup, M. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02855-14 · Cited by 95 · see citing works

Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms incyp51A, Upregulation ofcyp51A, and Integration and Activation of TransposonAtf1in thecyp51APromoter

Albarrag, A., Anderson, M. J., Howard, S. J., Robson, G., Warn, P. A., Sanglard, D., & Denning, D. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00517-11 · Cited by 94 · see citing works

The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in <i><scp>C</scp>andida albicans</i>

Sasse, C., Dunkel, N., Schäfer, T., Schneider, S., Dierolf, F., Ohlsen, K., & Morschhäuser, J. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08210.x · Cited by 93 · see citing works

Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control

Yiannakis, E. P., & Boswell, T. C. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.01.018 · Cited by 92 · see citing works

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates

Guinea, J., Verweij, P. E., Meletiadis, J., Mouton, J. W., Barchiesi, F., Arendrup, M. C., Arendrup, M. C., Arıkan-Akdağlı, S., Barchiesi, F., Castanheira, M., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.09.008 · Cited by 91 · see citing works

Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients

Reséndiz-Sharpe, A., Mercier, T., Lestrade, P. P. A., van der Beek, M. T., Borne, P. A. V. D., Cornelissen, J. J., de Kort, E., Rijnders, B. J. A., Schauwvlieghe, A. F. A. D., Verweij, P. E., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz258 · Cited by 91 · see citing works

The Genetic Basis of Resistance to 5-Fluorocytosine in Candida Species and Cryptococcus Neoformans

Whelan, W. L. (1987) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418709104447 · Cited by 88 · see citing works

High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates

Buied, A., Moore, C. B., Denning, D. W., & Bowyer, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks451 · Cited by 88 · see citing works

Pneumocystis cariniiCytochrome b Mutations Are Associated with Atovaquone Exposure in Patients with AIDS

Kazanjian, P. H., Armstrong, W. S., Hossler, P. A., Huang, L., Beard, C. B., Carter, J. V., Crane, L. R., Duchin, J. S., Burman, W. J., Richardson, J. D., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318835 · Cited by 87 · see citing works

Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China

Chen, Y., Lu, Z., Zhao, J., Zou, Z., Gong, Y., Qu, F., Bao, Z., Qiu, G.-B., Song, M., Zhang, Q., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01005-16 · Cited by 86 · see citing works

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran, T., Sartori, B., Sappl, L., Aigner, M., Sánchez, F., Rezusta, A., Chowdhary, A., Taj‐Aldeen, S. J., Arendrup, M. C., Oliveri, S. M., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00516 · Cited by 83 · see citing works

Frequency of <i>fks</i> Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Castanheira, M., Woosley, L. N., Messer, S. A., Diekema, D. J., Jones, R. N., & Pfaller, M. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01674-13 · Cited by 82 · see citing works

Cross-resistance to polyene and azole drugs in Cryptococcus neoformans

Joseph‐Horne, T., Hollomon, D. W., Loeffler, R. S. T., & Kelly, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1526 · Cited by 81 · see citing works

SREBP-Dependent Triazole Susceptibility in Aspergillus fumigatus Is Mediated through Direct Transcriptional Regulation oferg11A(cyp51A)

Blosser, S. J., & Cramer, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05027-11 · Cited by 79 · see citing works

Functional Analysis of <i>cis</i> - and <i>trans</i> -Acting Elements of the <i>Candida albicans CDR2</i> Promoter with a Novel Promoter Reporter System

Coste, A. T., Crittin, J., Bauser, C., Rohde, B., & Sanglard, D. (2009) · Eukaryotic Cell · doi:10.1128/ec.00069-09 · Cited by 79 · see citing works

Aspergillus Species and Antifungals Susceptibility in Clinical Setting in the North of Portugal: Cryptic Species and Emerging Azoles Resistance in A. fumigatus

Pinto, E., Monteiro, C., Maia, M., Faria, M. Â., Lopes, V., Lameiras, C., & Pinheiro, D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01656 · Cited by 79 · see citing works

Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms

Sanglard, D., & Coste, A. T. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02157-15 · Cited by 78 · see citing works

Onychomycosis Insensitive to Systemic Terbinafine and Azole Treatments Reveals Non-Dermatophyte Moulds as Infectious Agents

Baudraz-Rosselet, F., Ruffieux, C., Lurati, M., et al. (2010) · Dermatology · doi:10.1159/000277762 · Cited by 77 · see citing works

Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013–2018

Lestrade, P. P. A., Buil, J. B., van der Beek, M. T., Kuijper, E. J., van Dijk, K., Kampinga, G. A., Rijnders, B. J. A., Vonk, A. G., de Greeff, S. C., Schoffelen, A. F., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2607.200088 · Cited by 77 · see citing works

Clinical perspectives on echinocandin resistance among Candida species

Shields, R. K., Nguyen, M. H., & Clancy, C. J. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000215 · Cited by 75 · see citing works

Fluconazole resistance in cryptococcal disease: emerging or intrinsic?

Cheong, J. W. S., & McCormack, J. (2012) · Medical Mycology · doi:10.3109/13693786.2012.715763 · Cited by 75 · see citing works

Flucytosine Monotherapy for Cryptococcosis

Hospenthal, D. R., & Bennett, J. E. (1998) · Clinical Infectious Diseases · doi:10.1086/514669 · Cited by 75 · see citing works

Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients

Fischer, J., Koningsbruggen-Rietschel, S. V., Rietschel, E., Vehreschild, M. J. G. T., Wisplinghoff, H., Krönke, M., & Hamprecht, A. G. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku009 · Cited by 75 · see citing works

Trends in Azole Resistance in Aspergillus fumigatus, the Netherlands, 1994–2016

Buil, J. B., Snelders, E., Denardi, L. B., et al. (2018) · Emerging infectious diseases · doi:10.3201/eid2501.171925 · Cited by 75 · see citing works

Fluconazole tolerance in clinical isolates of Cryptococcus neoformans

Venkateswarlu, K., Taylor, M., Manning, N. J., Rinaldi, M. G., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.748 · Cited by 74 · see citing works

Molecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit

Dannaoui, É., Gabriel, F., Gaboyard, M., Lagardere, G., Audebert, L., Quesne, G., Godichaud, S., Verweij, P. E., Accoceberry, I., & Bougnoux, M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01032-17 · Cited by 72 · see citing works

Emergence of Echinocandin Resistance Due to a Point Mutation in the <i>fks1</i> Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis

Jiménez-Ortigosa, C., Moore, C., Denning, D. W., & Perlin, D. S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01277-17 · Cited by 72 · see citing works

Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans

Bastos, R. W., Carneiro, H. C. S., Oliveira, L. V. N., Rocha, K. M., Freitas, G. J. C., Costa, M. C., Magalhães, T. F. F., Carvalho, V. S. D., Rocha, C. E., Ferreira, G. F., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01179-17 · Cited by 72 · see citing works

Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes

Arendrup, M. C., Jørgensen, K. M., Guinea, J., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa111 · Cited by 72 · see citing works

Effects of Agricultural Fungicide Use on Aspergillus fumigatus Abundance, Antifungal Susceptibility, and Population Structure

Barber, A. E., Riedel, J., Sae-Ong, T., Kang, K., Brabetz, W., Panagiotou, G., Deising, H. B., & Kurzai, O. (2020) · mBio · doi:10.1128/mbio.02213-20 · Cited by 71 · see citing works

In Vitro Susceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole

Gregson, L., Goodwin, J., Johnson, A. N. B., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01141-13 · Cited by 70 · see citing works

Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.

Takahashi, T., Hosoya, N., Endo, T., Nakamura, T., Sakashita, H., Kimura, K., Ohnishi, K., Nakamura, Y., & Iwamoto, A. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3161-3164.2000 · Cited by 69 · see citing works

Correlation of In Vitro Azole Susceptibility with In Vivo Response in a Murine Model of Cryptococcal Meningitis

Vélez, J. D., Allendoerfer, R., Luther, M., Rinaldi, M. G., & Graybill, J. R. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.2.508 · Cited by 69 · see citing works

Positions and Numbers of <i>FKS</i> Mutations in Candida albicans Selectively Influence <i>In Vitro</i> and <i>In Vivo</i> Susceptibilities to Echinocandin Treatment

Lackner, M., Tscherner, M., Schaller, M., Kuchler, K., Mair, C., Sartori, B., Istel, F., Arendrup, M. C., & Lass-Flörl, C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00123-14 · Cited by 67 · see citing works

The T788G Mutation in the cyp51C Gene Confers Voriconazole Resistance in Aspergillus flavus Causing Aspergillosis

Liu, W. Y., Sun, Y., Chen, W., Liu, W., Wan, Z., Bu, D., & Li, R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05477-11 · Cited by 66 · see citing works

Azole-resistantAspergillus fumigatusin sawmills of Eastern France

Jeanvoine, A., Rocchi, S., Reboux, G., Morin‐Crini, N., Crini, G., & Millon, L. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13488 · Cited by 66 · see citing works

Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature review

Rouzaud, C., Chosidow, O., Brocard, A., et al. (2017) · Transplant Infectious Disease · doi:10.1111/tid.12799 · Cited by 66 · see citing works

Rapid Detection of <i>ERG11</i> -Associated Azole Resistance and <i>FKS</i> -Associated Echinocandin Resistance in Candida auris

Hou, X., Lee, A., Jiménez-Ortigosa, C., Kordalewska, M., Perlin, D. S., & Zhao, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01811-18 · Cited by 66 · see citing works

Efficacy of Amphotericin B in Combination with Flucytosine against Flucytosine-Susceptible or Flucytosine-Resistant Isolates of Cryptococcus neoformans during Disseminated Murine Cryptococcosis

Schwarz, P., Dromer, F., Lortholary, O., & Dannaoui, É. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.113-120.2006 · Cited by 65 · see citing works

Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients

Lamb, D. C., Corran, A. J., Baldwin, B. C., Kwon‐Chung, J., & Kelly, S. L. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00684-2 · Cited by 64 · see citing works

Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)- <scp>d</scp> -Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus

Satish, S., Jiménez-Ortigosa, C., Zhao, Y., Lee, M. H., Dolgov, E., Krüger, T., Park, S., Denning, D. W., Kniemeyer, O., Brakhage, A. A., et al. (2019) · mBio · doi:10.1128/mbio.00779-19 · Cited by 64 · see citing works

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

Fekkar, A., Dannaoui, É., Meyer, I., Imbert, S., Brossas, J., Uzunov, M., Mellon, G., Nguyen‐Quoc, S., Guiller, E., Caumes, É., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2096-9 · Cited by 63 · see citing works

A new mutation in the SQLE gene of Trichophyton mentagrophytes associated to terbinafine resistance in a couple with disseminated tinea corporis

Hsieh, A., Quenan, S., Riat, A., et al. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.100903 · Cited by 63 · see citing works

Characterization of Heteroresistance to Fluconazole among Clinical Isolates of <i>Cryptococcus neoformans</i>

Yamazumi, T., Pfaller, M. A., Messer, S. A., Houston, A. K., Boyken, L., Hollis, R. J., Furuta, I., & Jones, R. N. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.267-272.2003 · Cited by 62 · see citing works

Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India

Chowdhary, A., Kathuria, S., Singh, P. K., et al. (2014) · Mycoses · doi:10.1111/myc.12234 · Cited by 62 · see citing works

Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method

Helleberg, M., Jørgensen, K. M., Hare, R. K., Datcu, R., Chowdhary, A., & Arendrup, M. C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02438-19 · Cited by 61 · see citing works

Belgian National Survey on Tinea Capitis: Epidemiological Considerations and Highlight of Terbinafine-Resistant T. mentagrophytes with a Mutation on SQLE Gene

Sacheli, R., Harag, S., Dehavay, F., Evrard, S., Rousseaux, D., Bahun, A. A., Seidel, L., Laffineur, K., Lagrou, K., & Hayette, M. (2020) · Journal of Fungi · doi:10.3390/jof6040195 · Cited by 61 · see citing works

Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs Directly from Plasma Samples

White, P. L., Posso, R. B., & Barnes, R. A. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00411-17 · Cited by 61 · see citing works

Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes

Jensen, R. H., Hagen, F., Astvad, K. M. T., Tyron, A., Meis, J. F. G. M., & Arendrup, M. C. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.001 · Cited by 59 · see citing works

Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing

Wang, H., Kong, F., Sorrell, T. C., Wang, B., McNicholas, P., Pantarat, N., Ellis, D., Xiao, M., Widmer, F., & Chen, S. C. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-167 · Cited by 58 · see citing works

High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy

Ponce, C. A., Chabé, M., George, C., Cárdenas, A., Durán, L., Guerrero, J., Bustamante, R. I., Matos, O., Huang, L., Miller, R. F., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01290-16 · Cited by 58 · see citing works

Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins

Thornewell, S. J., Peery, R. B., & Skatrud, P. L. (1997) · Gene · doi:10.1016/s0378-1119(97)00421-6 · Cited by 57 · see citing works

Overview of Commercially Available PCR Assays for the Detection of Aspergillus spp. DNA in Patient Samples

Rath, P.-M., & Steinmann, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00740 · Cited by 57 · see citing works

FKS2 and FKS3 Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility

Suwunnakorn, S., Wakabayashi, H., Kordalewska, M., Perlin, D. S., & Rustchenko, E. P. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02299-17 · Cited by 55 · see citing works

Next-generation sequencing offers new insights into the resistance ofCandidaspp. to echinocandins and azoles

Garnaud, C., Botterel, F., Sertour, N., Bougnoux, M., Dannaoui, É., Larrat, S., Hennequin, C., Guinea, J., Cornet, M., & Maubon, D. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv139 · Cited by 54 · see citing works

In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR120) inAspergillus fumigatus cyp51A, Denmark

Hare, R. K., Gertsen, J. B., Astvad, K. M. T., Degn, K., Løkke, A., Stegger, M., Andersen, P. S., Kristensen, L., & Arendrup, M. C. (2019) · Emerging infectious diseases · doi:10.3201/eid2503.180297 · Cited by 54 · see citing works

Sulfa Use, Dihydropteroate Synthase Mutations, andPneumocystis jiroveciiPneumonia

Stein, C. R., Poole, C., Kazanjian, P. H., & Meshnick, S. R. (2004) · Emerging infectious diseases · doi:10.3201/eid1010.040362 · Cited by 53 · see citing works

Multiple cyp51A -Based Mechanisms Identified in Azole-Resistant Isolates of Aspergillus fumigatus from China

Liu, M., Zeng, R., Zhang, L., Li, D., Lv, G., Shen, Y., Zheng, H., Zhang, Q., Zhao, J., Zheng, N., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00003-15 · Cited by 53 · see citing works

Resistance Mechanism in a Terbinafine-Resistant Strain of Microsporum canis

Kano, R., Hsiao, Y., Han, H. S., et al. (2018) · Mycopathologia · doi:10.1007/s11046-018-0242-0 · Cited by 53 · see citing works

Mediator Tail Module Is Required for Tac1-Activated <i>CDR1</i> Expression and Azole Resistance in Candida albicans

Liu, Z., & Myers, L. C. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01342-17 · Cited by 52 · see citing works

The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus

Buil, J. B., Hare, R. K., Zwaan, B. J., Arendrup, M. C., Melchers, W. J. G., & Verweij, P. E. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007858 · Cited by 52 · see citing works

Combination of Amphotericin B with Flucytosine Is Active In Vitro against Flucytosine-Resistant Isolates of Cryptococcus neoformans

Schwarz, P., Janbon, G., Dromer, F., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00446-06 · Cited by 51 · see citing works

Pyrosequencing To Detect Mutations in FKS1 That Confer Reduced Echinocandin Susceptibility in Candida albicans

Wiederhold, N. P., Grabinski, J. L., García‐Effrón, G., Perlin, D. S., & Lee, S. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00959-08 · Cited by 51 · see citing works

Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia.

Visconti, E., Ortona, E., Mencarini, P., Margutti, P., Marinaci, S., Zolfo, M., Siracusano, A., & Tamburrini, E. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00460-5 · Cited by 50 · see citing works

Sulfa Resistance and Dihydropteroate Synthase Mutants in RecurrentPneumocystis cariniiPneumonia

Nahimana, A., Rabodonirina, M., Helweg‐Larsen, J., Meneau, I., Francioli, P. B., Billé, J., & Hauser, P. M. (2003) · Emerging infectious diseases · doi:10.3201/eid0907.020753 · Cited by 50 · see citing works

Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans

Júnior, L. R. B., Gast, C. E., Bruzual, I., & Wong, B. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku554 · Cited by 49 · see citing works

Compensatory expression of multidrug-resistance genes encoding ABC transporters in dermatophytes

Martins, M. P., Franceschini, A. C. C., Jacob, T. R., Rossi, A., & Martinez-Rossi, N. M. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000268 · Cited by 49 · see citing works

The first report of terbinafine resistance Microsporum canis from a cat

Hsiao, Y., Chen, C., Han, H. S., et al. (2018) · Journal of Veterinary Medical Science · doi:10.1292/jvms.17-0680 · Cited by 49 · see citing works

Rapid detection of terbinafine resistance in Trichophyton species by Amplified refractory mutation system-polymerase chain reaction

Shankarnarayan, S. A., Shaw, D., Sharma, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58187-0 · Cited by 48 · see citing works

Interhuman Transmission as a Potential Key Parameter for Geographical Variation in the Prevalence ofPneumocystis jiroveciiDihydropteroate Synthase Mutations

Hauser, P. M., Nahimana, A., Taffé, P., Weber, R. K., Francioli, P. B., Billé, J., & Rabodonirina, M. (2010) · Clinical Infectious Diseases · doi:10.1086/655145 · Cited by 47 · see citing works

Clinical Significance and Phylogenetic Relationship of Novel Australian Pneumocystis jirovecii Genotypes

van Hal, S. J., Gilgado, F., Doyle, T., Barratt, J., Stark, D. J., Meyer, W., & Harkness, J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02102-08 · Cited by 47 · see citing works

In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates

Rezaei‐Matehkolaei, A., Khodavaisy, S., Alshahni, M. M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02423-17 · Cited by 47 · see citing works

Molecular Detection of Azole-Resistant Aspergillus fumigatus in Clinical Samples

Buil, J. B., Zoll, J., Verweij, P. E., & Melchers, W. J. G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00515 · Cited by 47 · see citing works

High-Frequency Direct Detection of Triazole Resistance in Aspergillus fumigatus from Patients with Chronic Pulmonary Fungal Diseases in India

Singh, A. K., Sharma, B., Mahto, K. K., Meis, J. F. G. M., & Chowdhary, A. (2020) · Journal of Fungi · doi:10.3390/jof6020067 · Cited by 47 · see citing works

New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae

Costa, C., Ponte, A., Pais, P., Santos, R., Cavalheiro, M., Yaguchi, T., Chibana, H., & Teixeira, M. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135110 · Cited by 46 · see citing works

Terbinafine‐resistant strain of Trichophyton interdigitale strain isolated from a tinea pedis patient

Hiruma, J., Kitagawa, H., Noguchi, H., et al. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14809 · Cited by 46 · see citing works

A Rapid and Automated Sample-to-Result Candida auris Real-Time PCR Assay for High-Throughput Testing of Surveillance Samples with the BD Max Open System

Leach, L., Russell, A., Zhu, Y., Chaturvedi, S., & Chaturvedi, V. P. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00630-19 · Cited by 46 · see citing works

Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations

Montesinos, I., Delforge, M., Ajjaham, F., Brancart, F., Hites, M., Jacobs, F., & Denis, O. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.10.005 · Cited by 45 · see citing works

Evaluation of DermaGenius ® resistance real‐time polymerase chain reaction for rapid detection of terbinafine‐resistant Trichophyton species

Singh, A. K., Singh, P., Dingemans, G., et al. (2021) · Mycoses · doi:10.1111/myc.13271 · Cited by 45 · see citing works

An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections

Jenks, J. D., White, P. L., Kidd, S. E., Goshia, T., Fraley, S. I., Hoenigl, M., & Thompson, G. R. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2267977 · Cited by 61 · see citing works

Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance

Su, Y., Li, Y., Yi, Q., Xu, Y., Sun, T., & Li, Y. (2025) · Journal of Fungi · doi:10.3390/jof11020143 · Cited by 18 · see citing works

Study progress and clinical application on antifungal drugs

Qin, C. (2003) · The Journal of Pharmaceutical Practice

Antifungals and antifungal drug discovery.

Calderone, R., Fonzi, W. A., Gay‐Andrieu, F., et al. (2012) · CABI eBooks · doi:10.1079/9781845939434.0247 · Cited by 5 · see citing works

Progress on Research of Antifungal Drugs

Hong, T. N. (2006) · Tianran chanwu yanjiu yu kaifa · Cited by 1 · see citing works

Novel antifungal drugs

DiDomenico, B. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00009-0 · Cited by 91 · see citing works

Antifungal Pharmacokinetics and Pharmacodynamics

Hope, W. W., & Andes, D. R. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3323-5_15 · Cited by 1 · see citing works